TY - JOUR
T1 - Liver transplantation
AU - Zetterman, R. K.
PY - 1991
Y1 - 1991
N2 - Liver transplantation is now the accepted treatment for patients with complications of endstage liver disease and selected metabolic disorders. Unfortunately, the availability of donor organs is still a significant problem, and patients may die while awaiting transplantation. The development of techniques for surgical reduction of liver size and the use of older donor livers has made more organs available and has decreased the risk of patients dying on the waiting list. New antirejection agents, such as FK-506, are also being developed that may improve eventual outcome. In this discussion, we review these and other recent developments of liver transplantation.
AB - Liver transplantation is now the accepted treatment for patients with complications of endstage liver disease and selected metabolic disorders. Unfortunately, the availability of donor organs is still a significant problem, and patients may die while awaiting transplantation. The development of techniques for surgical reduction of liver size and the use of older donor livers has made more organs available and has decreased the risk of patients dying on the waiting list. New antirejection agents, such as FK-506, are also being developed that may improve eventual outcome. In this discussion, we review these and other recent developments of liver transplantation.
UR - http://www.scopus.com/inward/record.url?scp=0025802153&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0025802153&partnerID=8YFLogxK
U2 - 10.1097/00001574-199106000-00003
DO - 10.1097/00001574-199106000-00003
M3 - Review article
AN - SCOPUS:0025802153
SN - 0267-1379
VL - 7
SP - 364
EP - 369
JO - Current opinion in gastroenterology
JF - Current opinion in gastroenterology
IS - 3
ER -